Published in Prostaglandins on January 01, 1993
Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet (2001) 0.98
Platelet-activating factor: an inflammatory mediator in the acute phase of allergic conjunctivitis in a guinea-pig model. Mediators Inflamm (1995) 0.89
Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study. Drug Des Devel Ther (2016) 0.75
Protective effect of high concentration of BN52021 on retinal contusion in cat eyes. BMC Ophthalmol (2015) 0.75
Perspectives in platelet-activating factor research. Pharmacol Rev (1987) 5.27
Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91
Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis (1987) 1.87
The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology (1996) 1.49
Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol (1987) 1.46
Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats. Gastroenterology (1991) 1.43
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. Agents Actions (1989) 1.42
Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists. Clin Exp Allergy (1995) 1.42
Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35
Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology (1993) 1.35
Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med (1984) 1.30
Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs (1991) 1.25
Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties. Biochem Biophys Res Commun (1988) 1.20
Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest (1989) 1.19
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Eur J Pharmacol (1986) 1.17
Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. Invest Ophthalmol Vis Sci (1991) 1.17
Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest (1986) 1.17
Na+ and K+ transport damage induced by oxygen free radicals in human red cell membranes. J Biol Chem (1983) 1.11
The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. Eur J Pharmacol (1988) 1.11
Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem (1990) 1.10
Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig. Biochem Biophys Res Commun (1989) 1.10
Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia. J Appl Physiol (1985) (1988) 1.09
Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig. Curr Eye Res (1985) 1.07
Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challenge. J Allergy Clin Immunol (1984) 1.06
Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol (1990) 1.03
Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS Lett (1992) 1.03
Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Eur J Pharmacol (1986) 1.02
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. Lancet (1985) 1.01
HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefes Arch Clin Exp Ophthalmol (1996) 1.01
Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells. J Immunol (1990) 1.01
Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc Ophthalmol (1986) 1.00
Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: protective effect of flavonoids. Biochem Pharmacol (1983) 1.00
Characterization of effect of N-formyl-methionyl-leucyl-phenylalanine on leukotriene synthesis in human polymorphonuclear leukocytes. Inflammation (1985) 1.00
Stimulation of K+ fluxes by diuretic drugs in human red cells. Biochem Pharmacol (1984) 0.99
Vascular mechanism of action of endothelin-1: effect of Ca2+ antagonists. J Cardiovasc Pharmacol (1989) 0.99
Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils. Prostaglandins Leukot Essent Fatty Acids (1997) 0.99
Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. Prostaglandins (1986) 0.98
PAF. A review of its effects, antagonists and possible future clinical implications (Part II). Drugs (1991) 0.97
Effect of O-(beta-hydroxyethyl)-rutoside on red cell and platelet functions in man. Bibl Anat (1973) 0.97
Comparison of enzymes of tears, lacrimal gland fluid and lacrimal gland tissue in the rat. Exp Eye Res (1984) 0.97
Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion. Free Radic Res Commun (1991) 0.97
Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea (1993) 0.96
Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea (1993) 0.95
Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. Biochem Biophys Res Commun (1987) 0.95
Corneal epithelial permeability after instillation of ophthalmic solutions containing local anaesthetics and preservatives. Curr Eye Res (1988) 0.94
Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes. J Immunol (1992) 0.94
Down-regulation of endothelin binding sites in rat vascular smooth muscle cells. Am J Hypertens (1990) 0.94
Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Commun (1989) 0.94
Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells. J Neurosci Res (1989) 0.93
Bacteriochlorin a, a new photosensitizer in photodynamic therapy. In vivo results. Invest Ophthalmol Vis Sci (1990) 0.93
Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br J Pharmacol (1990) 0.93
Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. Immunopharmacology (1985) 0.93
PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Prostaglandins (1988) 0.93
Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol (1994) 0.92
Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats. Life Sci (1989) 0.92
Incidence of ocular side effects of topical beta blockers in the Netherlands. Br J Ophthalmol (2000) 0.92
Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins (1988) 0.91
Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Prog Lipid Res (1986) 0.91
Absence of implication of L-arginine/nitric oxide pathway on neuronal cell injury induced by L-glutamate or hypoxia. Biochem Biophys Res Commun (1991) 0.91
Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs. Br J Pharmacol (1989) 0.90
Release of adenosine from human neutrophils stimulated by platelet activating factor, leukotriene B(4) and opsonized zymosan. Mediators Inflamm (1992) 0.90
Comparison of the bronchopulmonary and pressor activities of endothelin isoforms ET-1, ET-2, and ET-3 and characterization of their binding sites in guinea pig lung. Am Rev Respir Dis (1991) 0.90
Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. Prostaglandins (1987) 0.90
Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils. Br J Pharmacol (1994) 0.90
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res (1986) 0.89
Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Eur J Pharmacol (1986) 0.89
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. Prostaglandins (1985) 0.89
Lipoteichoic acid: a new inducer of nitric oxide synthase. J Cardiovasc Pharmacol (1992) 0.89
Paf-induced release of spasmogens from guinea-pig lungs. Br J Pharmacol (1989) 0.88
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Agents Actions (1986) 0.88
Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1987) 0.88
Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. J Pharmacol Exp Ther (1990) 0.88
Alpha-adrenoceptor control of peroxidase secretion from rat lacrimal gland cells in vitro. Exp Eye Res (1982) 0.88
Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model. Gastroenterology (1992) 0.88
Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. J Immunol (1988) 0.88
Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability. J Lipid Mediat (1990) 0.88
Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun (1987) 0.88
Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease. J Lipid Mediat (1992) 0.88
In vivo ultrasound backscattering estimation for tumour diagnosis: an animal study. Ultrasound Med Biol (1989) 0.88
The effect of lipid peroxidation on transport function in human erythrocytes. Biomed Biochim Acta (1983) 0.88
Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 0.87
Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by 'diuretic-antihypertensive' drugs. Biochem Pharmacol (1984) 0.87
Endothelin-induced constriction of guinea pig airways: role of platelet-activating factor. Eur J Pharmacol (1990) 0.87
Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog. Circ Shock (1991) 0.87
Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist. Nephrol Dial Transplant (1989) 0.87
Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Pharmacol Res Commun (1986) 0.87
Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat. Pharmacol Res (1997) 0.87
Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat. J Pharmacol Exp Ther (1990) 0.87
Studies on leukotriene B4 omega-oxidation in human leukocytes. Can J Biochem Cell Biol (1984) 0.87
Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats. Braz J Med Biol Res (1989) 0.86
Janus green vital staining of the cornea. Doc Ophthalmol (1983) 0.86
Bronchial hyperresponsiveness and cellular infiltration in the lung of guinea-pigs sensitized and challenged by aerosol. Clin Exp Allergy (1991) 0.86
Comparison of the effects of intra-arterial and aerosol administration of endothelin-1 (ET-1) in the guinea-pig isolated lung. Br J Pharmacol (1991) 0.86
Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells. Clin Immunol Immunopathol (1990) 0.86
Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Pharmacol Res Commun (1986) 0.86
Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Lab Invest (1994) 0.86
Different regulation of vascular tone by angiotensin II and endothelin-1 in rat aorta. Eur J Pharmacol (1991) 0.86
Free radical-mediated effects in reperfusion injury: a histologic study with superoxide dismutase and EGB 761 in rat retina. Ophthalmic Res (1991) 0.86